Skip to content
ThermaSolutions – Hyperthermic Intraperitoneal ChemotherapyThermaSolutions – Hyperthermic Intraperitoneal Chemotherapy
  • Request Info
  • Contact
  • Our Story
  • Products
    • HT-2000
    • HT-2500 (CE)
    • HurriChem Device Kit (FDA)
    • HurriChem Nebulizer (CE)
    • Whole Body Hyperthermia: HEATT
    • Disposable HIPEC Procedure Kits
    • Chemo Waste Products (US)
    • Isolated Limb Products
    • SurgiChem Dual Injector Pump
    • Thermal Insulators (US)
    • Lasso Tubing Drains
    • ThermoChem Accessories
  • Distributors
    • Find Us
    • Distributors Only
  • Training & Support
    • IPH Kit: Training Videos
    • TSP Kits: Training Videos
    • HIPEC Program Support
    • HIPEC Resources
    • Support for HT-1000
    • Product Manuals & IFU
  • Job Openings
  • News
News

ThermaSolutions at SGO in Phoenix! (March 18-21, 2022)

Posted on February 6, 2022March 22, 2022 by Dean Wennerberg

ThermaSolutions was proud to be an ambassador for HIPEC at the Society of Gynecologic Oncology Annual Meeting in Phoenix from March 18-21, 2022.

This entry was posted in News. Bookmark the permalink.
SSO Advanced Cancer Therapies – March 11-12, 2022 – Dallas, TX
ESSO Online Course on the Management of HIPEC after CRS – 16-17 March 2022
Categories
  • HIPEC Resources
  • News
Recent Posts
  • 2023 PSOGI Congress – Venice, Italy: Introducing the future of HIPEC at ThermaSolutions……..
  • Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course: 10-12 July 2023 – Singapore
  • 15th Francophone Day of Primary and Metastatic Peritoneal Diseases – June 23, 2023
  • ESSO-EYSAC Hands on Course on Laparoscopy in the Management of Peritoneal Carcinomatosis 5-6 June, 2023 – Universidad Miguel Hernández, Alicante, SP
  • Karolinska University Hospital – Nordic HIPEC Meeting 4-5 May 2023
Past Events

Our Certifications

21 CFR Quality Systems Regulation Part 820 of the Federal Food and Drug Administration (FDA).
EN/ISO 13485:2016 • MDD 93/42/EEC

Follow Us

U.S. Headquarters

1889 Buerkle Road
White Bear Lake, MN 55110
Tel. +1 651 209 3900
Fax +1 651 209 3903

Toll Free: +1 877 952 6100

General Questions:

International Office

Takkebijsters 41
4817 BL Breda
The Netherlands
Tel. +31 76 579 1144

Direct:

Products

  • ThermoChemTM HT-2000
  • ThermoChemTM HT-2500
  • Disposable HIPEC Procedure Kits
  • Find Us
  • Distributors Only

Training & Support 

  • IPH Kit: Training Videos
  • TSP Kit: Training Videos
  • HIPEC Program Support
  • HIPEC Resources
  • Support for HT-1000

*FDA Disclaimer: ThermoChem™ HT-2000 (or HT-1000) has not been cleared for use to treat any specific disease state or condition. Chemotherapy drugs used during the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure are currently approved for the treatment of certain cancers. A number of clinical studies and literature exist regarding the use of HIPEC in the peritoneum using intraperitoneal heating devices, such as the ThermoChem™ HT-2000 (or HT-1000). Physicians should decide which drugs to use with ThermoChem™ HT-2000 (or HT-1000) based upon their good judgment and understanding of the strengths and limitations of the data, and should consider the literature to guide their use of HIPEC with ThermoChem™ HT-2000 (or HT-1000).

  • Home
  • Request Info
  • News
  • Privacy statement
  • Disclaimer
2023 © ThermaSolutions
Site by Gasman Design
  • Home
  • Our Story
  • Products
    • HT-2000
    • HT-2500 (CE)
    • HurriChem Device Kit (FDA)
    • HurriChem Nebulizer (CE)
    • Whole Body Hyperthermia: HEATT
    • Disposable HIPEC Procedure Kits
    • Chemo Waste Products (US)
    • Isolated Limb Products
    • SurgiChem Dual Injector Pump
    • Thermal Insulators (US)
    • Lasso Tubing Drains
    • ThermoChem Accessories
  • Distributors
    • Find Us
    • Distributors Only
  • Training & Support
    • IPH Procedure Kit: Training Videos
    • TSP Kits: Training Videos
    • HIPEC Program Support
    • HIPEC Resources
    • Support for HT-1000
    • Product Manuals & IFU
  • Request Info
  • Job Openings
  • News
  • Contact Us